Angiotensin II (Ang II), by activating the angiotensin II type 1 receptor (AGTR1), leads to pathological changes in the knee joints of experimental osteoarthritis mice, such as articular cartilage degradation, subchondral bone sclerosis, inflammation, and synovial damage. Here, AGT is linked to osteoarthritis.